首页 > 最新文献

Translational gastroenterology and hepatology最新文献

英文 中文
REGγ deficiency ameliorates hepatic ischemia and reperfusion injury in a mitochondrial p66shc dependent manner in mice. REGγ的缺乏能以线粒体p66shc依赖的方式改善小鼠肝缺血和再灌注损伤。
IF 3.8 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-10-16 eCollection Date: 2024-01-01 DOI: 10.21037/tgh-24-46
Long Guo, Qing Yang, Jiali Zhu, Jinbao Li

Background: Hepatic ischemia and reperfusion (I/R) injury is a common problem faced by patients undergoing clinical liver transplantation and hepatectomy, but the specific mechanism of liver I/R injury has not been fully elucidated. The protein degradation complex 11S proteasome is involved in apoptosis, proliferation and cell cycle regulation by regulating the 11S proteasome regulatory complex (REG)γ. The main objective of this study is to explore the role and specific mechanism of REGγ in liver I/R.

Methods: By constructing a model of in vivo hepatic I/R injury in mice and a model of hypoxia and reoxygenation (H/R) in isolated hepatocytes. First, the REGγ expression were detected during hepatic I/R in mice. Second, to investigate the effects of REGγ knockout (KO) on liver necrosis, inflammatory response, apoptosis and mitochondrial function. Finally, mouse liver Src homology collagen (p66shc) mitochondrial translocation was detected.

Results: The expression of REGγ was up-regulated during hepatic I/R. REGγ KO had significantly reduced liver tissue infarct size, liver transaminases, inflammatory cells infiltration, inflammatory cytokine and activation of nuclear factor kappa-B (NF-κB) signaling pathway and cell apoptosis. REGγ KO had significantly alleviated the mitochondrial damage, decreased the up-regulated level of cytochrome C, reactive oxygen species (ROS). REGγ KO had significantly reduced p66shc mitochondrial translocation in mice.

Conclusions: The experimental results of this study indicated that REGγ has an important role in preventing liver I/R injury and may play a role through the mitochondrial p66shc signaling pathway.

背景:肝脏缺血再灌注(I/R)损伤是临床肝移植和肝切除术患者面临的共同问题,但肝脏I/R损伤的具体机制尚未完全阐明。蛋白质降解复合物11S蛋白酶体通过调控11S蛋白酶体调控复合物(REG)γ参与细胞凋亡、增殖和细胞周期调控。本研究的主要目的是探讨REGγ在肝脏I/R中的作用和具体机制:方法:通过构建小鼠体内肝I/R损伤模型和离体肝细胞缺氧再氧(H/R)模型。首先,检测小鼠肝I/R过程中REGγ的表达。其次,研究 REGγ 基因敲除(KO)对肝坏死、炎症反应、细胞凋亡和线粒体功能的影响。最后,检测小鼠肝脏Src同源胶原(p66shc)线粒体转位:结果:REGγ的表达在肝脏I/R过程中上调。结果:REGγ的表达在肝脏I/R过程中上调,REGγ KO能明显减少肝组织梗死面积、肝脏转氨酶、炎症细胞浸润、炎症细胞因子和核因子卡巴-B(NF-κB)信号通路的激活以及细胞凋亡。REGγ KO能明显减轻线粒体损伤,降低细胞色素C和活性氧(ROS)的上调水平。REGγ KO能明显减少小鼠线粒体p66shc的转位:本研究的实验结果表明,REGγ在预防肝脏I/R损伤中具有重要作用,并可能通过线粒体p66shc信号通路发挥作用。
{"title":"REGγ deficiency ameliorates hepatic ischemia and reperfusion injury in a mitochondrial p66shc dependent manner in mice.","authors":"Long Guo, Qing Yang, Jiali Zhu, Jinbao Li","doi":"10.21037/tgh-24-46","DOIUrl":"10.21037/tgh-24-46","url":null,"abstract":"<p><strong>Background: </strong>Hepatic ischemia and reperfusion (I/R) injury is a common problem faced by patients undergoing clinical liver transplantation and hepatectomy, but the specific mechanism of liver I/R injury has not been fully elucidated. The protein degradation complex 11S proteasome is involved in apoptosis, proliferation and cell cycle regulation by regulating the 11S proteasome regulatory complex (REG)γ. The main objective of this study is to explore the role and specific mechanism of REGγ in liver I/R.</p><p><strong>Methods: </strong>By constructing a model of <i>in vivo</i> hepatic I/R injury in mice and a model of hypoxia and reoxygenation (H/R) in isolated hepatocytes. First, the REGγ expression were detected during hepatic I/R in mice. Second, to investigate the effects of REGγ knockout (KO) on liver necrosis, inflammatory response, apoptosis and mitochondrial function. Finally, mouse liver Src homology collagen (p66shc) mitochondrial translocation was detected.</p><p><strong>Results: </strong>The expression of REGγ was up-regulated during hepatic I/R. REGγ KO had significantly reduced liver tissue infarct size, liver transaminases, inflammatory cells infiltration, inflammatory cytokine and activation of nuclear factor kappa-B (NF-κB) signaling pathway and cell apoptosis. REGγ KO had significantly alleviated the mitochondrial damage, decreased the up-regulated level of cytochrome C, reactive oxygen species (ROS). REGγ KO had significantly reduced p66shc mitochondrial translocation in mice.</p><p><strong>Conclusions: </strong>The experimental results of this study indicated that REGγ has an important role in preventing liver I/R injury and may play a role through the mitochondrial p66shc signaling pathway.</p>","PeriodicalId":94362,"journal":{"name":"Translational gastroenterology and hepatology","volume":"9 ","pages":"62"},"PeriodicalIF":3.8,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11535816/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142585320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Liver transplantation for hepatocellular carcinoma: a proposal for including preoperative serological indicators improves the Milan criteria expanded. 肝细胞癌肝移植:建议纳入术前血清学指标,改进米兰标准扩展版。
IF 3.8 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-10-14 eCollection Date: 2024-01-01 DOI: 10.21037/tgh-24-40
Ning Jiao, Cheng Yan, Li He, Hai-Long Jin, Shuang Oiu, Chao Li, Zhi-Sheng Zheng, Bin Lu, Feng-Dong Wu, Yang Yang, Xin-Guo Chen, Qing Zhang

Background: Liver transplantation (LT) is the most effective and radical treatment for hepatocellular carcinoma (HCC). Most LT criteria are based on the morphological characteristics of tumors, which are not enough to predict the risk of tumor recurrence. It is found that some serological biomarkers can predict tumor recurrence and may be a good indicator for selecting suitable HCC patients for LT. This article aims to evaluate the predictive effect of preoperative serological indicators on long-term overall survival (OS) and tumor recurrence-free survival (TFS) of patients with HCC after LT, and to explore its significance for expanding the Milan criteria.

Methods: Clinical data of 253 patients after LT in HCC were collected retrospectively. The receiver operating characteristic curve was used to calculate the best cut-off value. χ2 test was used to analyze the correlation between preoperative serological indicators and tumor pathological features. Univariate and multivariate analyses were used to analyze the risk factors affecting the OS and TFS rates and the predictive values of different LT criteria were compared. Nomogram model was used to predict the OS and TFS rates of patients exceeding Milan criteria.

Results: Independent risk factors for poor OS and TFS rates were alpha-fetoprotein (AFP) >200 ng/mL, gamma-glutamyl transpeptidase (GGT) >80 IU/L, total tumor diameter (TTD) >8 cm and microsatellite lesions. Nomogram model showed patients beyond Milan criteria had better survival when AFP ≤200 ng/mL and GGT ≤80 IU/L or AFP >200 ng/mL, GGT ≤80 IU/L and TTD ≤8 cm. According to Milan criteria, AFP, GGT and TTD, Milan-AFP-GGT-TTD (M-AGT) criteria was established. There was no significant difference in OS and TFS rates among patients in M-AGT, Milan, Hangzhou, Malaya and the University of California at San Francisco (UCSF) criteria.

Conclusions: Preoperative serological indicators AFP and GGT can effectively predict long-term OS and TFS in HCC patients after LT. Establishing M-AGT criteria based on serological indicators is helpful to supplement the Milan criteria.

背景:肝移植(LT)是治疗肝细胞癌(HCC)最有效、最彻底的方法。大多数肝移植标准基于肿瘤的形态学特征,不足以预测肿瘤复发的风险。研究发现,一些血清学生物标志物可预测肿瘤复发,并可作为选择合适的 HCC 患者进行 LT 的良好指标。本文旨在评估术前血清学指标对HCC患者LT术后长期总生存(OS)和无肿瘤复发生存(TFS)的预测作用,并探讨其对扩展米兰标准的意义:方法:回顾性收集253例HCC患者LT术后的临床数据。采用接收者操作特征曲线计算最佳临界值。采用χ2检验分析术前血清学指标与肿瘤病理学特征之间的相关性。采用单变量和多变量分析影响OS和TFS率的风险因素,并比较不同LT标准的预测值。采用提名图模型预测超过米兰标准的患者的OS和TFS率:甲胎蛋白(AFP)>200 ng/mL、γ-谷氨酰转肽酶(GGT)>80 IU/L、肿瘤总直径(TTD)>8 cm和微卫星病变是影响OS和TFS率的独立风险因素。提名图模型显示,当 AFP ≤200 ng/mL、GGT ≤80 IU/L 或 AFP >200 ng/mL、GGT ≤80 IU/L 和 TTD ≤8 cm 时,超过米兰标准的患者生存率更高。根据米兰标准、AFP、GGT和TTD,制定了米兰-AFP-GGT-TTD(M-AGT)标准。M-AGT标准、米兰标准、杭州标准、马来亚标准和加州大学旧金山分校(UCSF)标准患者的OS和TFS率无明显差异:结论:术前血清学指标甲胎蛋白(AFP)和谷草转氨酶(GGT)可有效预测HCC患者LT术后的长期OS和TFS。结论:术前血清学指标 AFP 和 GGT 可有效预测 HCC 患者 LT 后的长期 OS 和 TFS。建立基于血清学指标的 M-AGT 标准有助于补充米兰标准。
{"title":"Liver transplantation for hepatocellular carcinoma: a proposal for including preoperative serological indicators improves the Milan criteria expanded.","authors":"Ning Jiao, Cheng Yan, Li He, Hai-Long Jin, Shuang Oiu, Chao Li, Zhi-Sheng Zheng, Bin Lu, Feng-Dong Wu, Yang Yang, Xin-Guo Chen, Qing Zhang","doi":"10.21037/tgh-24-40","DOIUrl":"10.21037/tgh-24-40","url":null,"abstract":"<p><strong>Background: </strong>Liver transplantation (LT) is the most effective and radical treatment for hepatocellular carcinoma (HCC). Most LT criteria are based on the morphological characteristics of tumors, which are not enough to predict the risk of tumor recurrence. It is found that some serological biomarkers can predict tumor recurrence and may be a good indicator for selecting suitable HCC patients for LT. This article aims to evaluate the predictive effect of preoperative serological indicators on long-term overall survival (OS) and tumor recurrence-free survival (TFS) of patients with HCC after LT, and to explore its significance for expanding the Milan criteria.</p><p><strong>Methods: </strong>Clinical data of 253 patients after LT in HCC were collected retrospectively. The receiver operating characteristic curve was used to calculate the best cut-off value. χ<sup>2</sup> test was used to analyze the correlation between preoperative serological indicators and tumor pathological features. Univariate and multivariate analyses were used to analyze the risk factors affecting the OS and TFS rates and the predictive values of different LT criteria were compared. Nomogram model was used to predict the OS and TFS rates of patients exceeding Milan criteria.</p><p><strong>Results: </strong>Independent risk factors for poor OS and TFS rates were alpha-fetoprotein (AFP) >200 ng/mL, gamma-glutamyl transpeptidase (GGT) >80 IU/L, total tumor diameter (TTD) >8 cm and microsatellite lesions. Nomogram model showed patients beyond Milan criteria had better survival when AFP ≤200 ng/mL and GGT ≤80 IU/L or AFP >200 ng/mL, GGT ≤80 IU/L and TTD ≤8 cm. According to Milan criteria, AFP, GGT and TTD, Milan-AFP-GGT-TTD (M-AGT) criteria was established. There was no significant difference in OS and TFS rates among patients in M-AGT, Milan, Hangzhou, Malaya and the University of California at San Francisco (UCSF) criteria.</p><p><strong>Conclusions: </strong>Preoperative serological indicators AFP and GGT can effectively predict long-term OS and TFS in HCC patients after LT. Establishing M-AGT criteria based on serological indicators is helpful to supplement the Milan criteria.</p>","PeriodicalId":94362,"journal":{"name":"Translational gastroenterology and hepatology","volume":"9 ","pages":"63"},"PeriodicalIF":3.8,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11535812/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142585313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hepatocellular carcinoma risk prediction and early detection in patients with metabolic dysfunction associated steatotic liver disease. 代谢功能障碍伴脂肪肝患者的肝细胞癌风险预测和早期检测。
IF 3.8 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-10-12 eCollection Date: 2024-01-01 DOI: 10.21037/tgh-24-41
Jeff Liang, Naomy Kim, Ju Dong Yang

The rising prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) and its more severe form, metabolic dysfunction-associated steatohepatitis (MASH), is closely linked with a heightened risk of hepatocellular carcinoma (HCC), the fourth leading cause of cancer-related deaths worldwide. Despite the elevated risk of HCC in patients with MASLD, the existing surveillance guidelines are inadequate, particularly for those without cirrhosis. This review evaluates current HCC surveillance practices in patients with MASLD and their shortcomings. It also highlights the critical need for enhanced HCC risk stratification and diagnostic accuracy through new techniques. In this review article, we performed a comprehensive literature review of studies focusing on HCC risk factors in MASLD/MASH patients from 2000 to 2023. We discussed that demographics, comorbidities, liver fibrosis, and genetic markers play critical roles in HCC risk stratification. Additionally, non-invasive tests (NITs) for fibrosis may improve the accuracy for HCC risk stratification and diagnosis. More recently, innovative approaches, such as machine learning techniques and liquid biopsy utilizing extracellular vesicles, cell-free DNA, and circulating tumor cells show promise in redefining early HCC detection. Thus, integrating these various risk factors could optimize early detection of HCC for the growing MASLD/MASH patient population. However, further research is needed to confirm their effectiveness and practical implementation in clinical settings.

代谢功能障碍相关性脂肪性肝病(MASLD)及其更严重的代谢功能障碍相关性脂肪性肝炎(MASH)发病率的上升与肝细胞癌(HCC)风险的增加密切相关,而肝细胞癌是全球癌症相关死亡的第四大原因。尽管 MASLD 患者罹患 HCC 的风险较高,但现有的监测指南并不完善,尤其是对于那些没有肝硬化的患者。本综述评估了目前对 MASLD 患者进行 HCC 监测的做法及其不足之处。文章还强调了通过新技术提高 HCC 风险分层和诊断准确性的迫切需要。在这篇综述文章中,我们对 2000 年至 2023 年有关 MASLD/MASH 患者 HCC 风险因素的研究进行了全面的文献综述。我们讨论了人口统计学、合并症、肝纤维化和遗传标记在 HCC 风险分层中的关键作用。此外,无创肝纤维化检测(NIT)可提高HCC风险分层和诊断的准确性。最近,机器学习技术和利用细胞外囊泡、无细胞 DNA 和循环肿瘤细胞的液体活检等创新方法有望重新定义早期 HCC 检测。因此,整合这些不同的风险因素可以优化对日益增多的MASLD/MASH患者群体的HCC早期检测。然而,还需要进一步的研究来证实它们的有效性以及在临床环境中的实际应用。
{"title":"Hepatocellular carcinoma risk prediction and early detection in patients with metabolic dysfunction associated steatotic liver disease.","authors":"Jeff Liang, Naomy Kim, Ju Dong Yang","doi":"10.21037/tgh-24-41","DOIUrl":"10.21037/tgh-24-41","url":null,"abstract":"<p><p>The rising prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) and its more severe form, metabolic dysfunction-associated steatohepatitis (MASH), is closely linked with a heightened risk of hepatocellular carcinoma (HCC), the fourth leading cause of cancer-related deaths worldwide. Despite the elevated risk of HCC in patients with MASLD, the existing surveillance guidelines are inadequate, particularly for those without cirrhosis. This review evaluates current HCC surveillance practices in patients with MASLD and their shortcomings. It also highlights the critical need for enhanced HCC risk stratification and diagnostic accuracy through new techniques. In this review article, we performed a comprehensive literature review of studies focusing on HCC risk factors in MASLD/MASH patients from 2000 to 2023. We discussed that demographics, comorbidities, liver fibrosis, and genetic markers play critical roles in HCC risk stratification. Additionally, non-invasive tests (NITs) for fibrosis may improve the accuracy for HCC risk stratification and diagnosis. More recently, innovative approaches, such as machine learning techniques and liquid biopsy utilizing extracellular vesicles, cell-free DNA, and circulating tumor cells show promise in redefining early HCC detection. Thus, integrating these various risk factors could optimize early detection of HCC for the growing MASLD/MASH patient population. However, further research is needed to confirm their effectiveness and practical implementation in clinical settings.</p>","PeriodicalId":94362,"journal":{"name":"Translational gastroenterology and hepatology","volume":"9 ","pages":"67"},"PeriodicalIF":3.8,"publicationDate":"2024-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11535805/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142585171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heterogeneity and prognosis of single organ metastases in gastric cancer. 胃癌单器官转移的异质性和预后。
IF 3.8 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-09-25 eCollection Date: 2024-01-01 DOI: 10.21037/tgh-24-11
Qian-Wen Zhao, Zheng Quan, Shan-Shan Liu, Yu-Dan Wang, Hao-Nan Guo

Background: While single organ metastases generally present a more optimistic prognosis compared to multiple metastases, the influence of the specific organ site for single organ metastases on prognosis remains undetermined. This retrospective study aimed to investigate the prognostic differences in late-stage gastric cancer with single organ metastasis.

Methods: Data for patients diagnosed with gastric cancer were retrieved from the Surveillance, Epidemiology, and End Results (SEER) database for survival analysis, covering years spanning from 2010 to 2016. Furthermore, Kaplan-Meier survival curves and Cox regression were utilized to analyze overall survival (OS) and disease-specific survival (DSS). Additionally, given the impact of confounders and bias on the results, prognosis was further analyzed using propensity score matching (PSM) and floating absolute risk methods.

Results: A cohort comprising 4,297 patients diagnosed with gastric cancer and exhibiting single organ metastasis was hereby enrolled. Liver metastasis was the most common (71% of the total), while brain metastasis accounted for the least (1.7% of the total). Compared to other metastases, patients with bone metastasis presented the worst OS [hazard ratio (HR), 1.319; 95% confidence interval (CI): 1.207-1.442; P<0.001], and this remained consistent even upon the application of floating absolute risk (HR, 1.10; 95% CI: 1.01-1.20) and PSM methods (HR, 1.187; 95% CI: 1.053-1.339; P=0.005). In addition, subgroup analysis and interaction tests of OS revealed an interaction between age (P=0.02), histological type (P=0.002), and bone metastasis.

Conclusions: In patients with single organ metastasis of gastric cancer, the prognosis varies by the metastatic site, with bone metastasis presenting the poorest outcome. Overall, this study forges a foundation for further research on the mechanisms and patterns of different metastatic sites in gastric cancer and informs treatment strategies.

背景:与多发转移相比,单器官转移的预后通常更为乐观,但单器官转移的具体器官部位对预后的影响仍未确定。这项回顾性研究旨在探讨单器官转移的晚期胃癌预后差异:方法:从监测、流行病学和最终结果(SEER)数据库中获取被诊断为胃癌的患者数据进行生存分析,时间跨度为2010年至2016年。此外,还利用卡普兰-梅耶生存曲线和考克斯回归分析总生存期(OS)和疾病特异性生存期(DSS)。此外,考虑到混杂因素和偏倚对结果的影响,还采用倾向得分匹配(PSM)和浮动绝对风险法对预后进行了进一步分析:该研究共纳入了4297名确诊为胃癌并出现单器官转移的患者。肝转移最常见(占总数的 71%),脑转移最少(占总数的 1.7%)。与其他转移灶相比,骨转移患者的OS最差[危险比(HR),1.319;95%置信区间(CI):1.207-1.442;PC结论:胃癌单器官转移患者的预后因转移部位而异,其中骨转移患者的预后最差。总之,这项研究为进一步研究胃癌不同转移部位的机制和模式奠定了基础,并为治疗策略提供了参考。
{"title":"Heterogeneity and prognosis of single organ metastases in gastric cancer.","authors":"Qian-Wen Zhao, Zheng Quan, Shan-Shan Liu, Yu-Dan Wang, Hao-Nan Guo","doi":"10.21037/tgh-24-11","DOIUrl":"10.21037/tgh-24-11","url":null,"abstract":"<p><strong>Background: </strong>While single organ metastases generally present a more optimistic prognosis compared to multiple metastases, the influence of the specific organ site for single organ metastases on prognosis remains undetermined. This retrospective study aimed to investigate the prognostic differences in late-stage gastric cancer with single organ metastasis.</p><p><strong>Methods: </strong>Data for patients diagnosed with gastric cancer were retrieved from the Surveillance, Epidemiology, and End Results (SEER) database for survival analysis, covering years spanning from 2010 to 2016. Furthermore, Kaplan-Meier survival curves and Cox regression were utilized to analyze overall survival (OS) and disease-specific survival (DSS). Additionally, given the impact of confounders and bias on the results, prognosis was further analyzed using propensity score matching (PSM) and floating absolute risk methods.</p><p><strong>Results: </strong>A cohort comprising 4,297 patients diagnosed with gastric cancer and exhibiting single organ metastasis was hereby enrolled. Liver metastasis was the most common (71% of the total), while brain metastasis accounted for the least (1.7% of the total). Compared to other metastases, patients with bone metastasis presented the worst OS [hazard ratio (HR), 1.319; 95% confidence interval (CI): 1.207-1.442; P<0.001], and this remained consistent even upon the application of floating absolute risk (HR, 1.10; 95% CI: 1.01-1.20) and PSM methods (HR, 1.187; 95% CI: 1.053-1.339; P=0.005). In addition, subgroup analysis and interaction tests of OS revealed an interaction between age (P=0.02), histological type (P=0.002), and bone metastasis.</p><p><strong>Conclusions: </strong>In patients with single organ metastasis of gastric cancer, the prognosis varies by the metastatic site, with bone metastasis presenting the poorest outcome. Overall, this study forges a foundation for further research on the mechanisms and patterns of different metastatic sites in gastric cancer and informs treatment strategies.</p>","PeriodicalId":94362,"journal":{"name":"Translational gastroenterology and hepatology","volume":"9 ","pages":"61"},"PeriodicalIF":3.8,"publicationDate":"2024-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11535815/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142585249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A new era with advanced immunotherapy. 先进免疫疗法的新时代
IF 3.8 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-09-24 eCollection Date: 2024-01-01 DOI: 10.21037/tgh-24-37
Claudia Badia Lopez, Elisabeth Ruijgrok, Casper H J van Eijck
{"title":"A new era with advanced immunotherapy.","authors":"Claudia Badia Lopez, Elisabeth Ruijgrok, Casper H J van Eijck","doi":"10.21037/tgh-24-37","DOIUrl":"10.21037/tgh-24-37","url":null,"abstract":"","PeriodicalId":94362,"journal":{"name":"Translational gastroenterology and hepatology","volume":"9 ","pages":"60"},"PeriodicalIF":3.8,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11535801/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142585134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Landscape of surgery in Crohn's disease across twenty years: insights from machine learning. 二十年来克罗恩病的手术情况:机器学习的启示。
IF 3.8 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-09-18 eCollection Date: 2024-01-01 DOI: 10.21037/tgh-23-113
Zhiyuan Zhou, Chaoran Yu, Bin Liu, Danhua Yao, Yuhua Huang, Pengfei Wang, Yousheng Li

Background: Crohn's disease continues to be a major component of inflammatory bowel disease with increasing incidence and prevalence. Increasing publications of surgery in Crohn's disease have significantly expanded the research scope. The aim of this study is to characterize main topics and a full landscape of surgery in Crohn's disease.

Methods: Studies of surgery in Crohn's disease from 2000 to 2020 were screened and retrieved from the Web of Science Core Collection database. Latent Dirichlet allocation (LDA), one of machine-learning algorithms for natural language processing, was employed for topic modeling. All the studies were processed, analyzed and visualized by R software, CiteSpace and Gephi.

Results: A total of 3,697 original publications were identified from the database. USA was the leading country with the most top institutions such as Cleveland Clin Florida and Mayo Clinic and Mayo Foundation. Increasing impact of institutions from Korea and China was also noticed. Bo Shen was the leading author in publication. A machine learning based topic modeling identified major clusters, including disease assessment, surgical treatment and complications, risk factors and epidemiology, disease development and diagnosis, target treatment and recurrence. Three topics attracted continuous high research attention, including expression of intestinal cell, perianal fistula and laparoscopic and open operation.

Conclusions: This study identified key topics relating to the development of surgery in Crohn's disease, and provided bibliometric insights and perspectives for future development in the field of surgery in Crohn's disease.

背景:克罗恩病仍然是炎症性肠病的主要组成部分,其发病率和流行率不断上升。有关克罗恩病外科手术的论文越来越多,大大扩展了研究范围。本研究的目的是描述克罗恩病外科手术的主要课题和全貌:方法:从 Web of Science Core Collection 数据库中筛选并检索了 2000 年至 2020 年有关克罗恩病手术治疗的研究。采用自然语言处理的机器学习算法之一 Latent Dirichlet allocation (LDA) 进行主题建模。所有研究均由 R 软件、CiteSpace 和 Gephi 进行处理、分析和可视化:结果:数据库中共识别出 3,697 篇原创论文。美国是拥有最多顶级机构的主要国家,如佛罗里达州克利夫兰诊所、梅奥诊所和梅奥基金会。韩国和中国机构的影响力也在增加。沈波是发表论文的主要作者。基于机器学习的主题建模确定了主要的研究集群,包括疾病评估、手术治疗和并发症、风险因素和流行病学、疾病发展和诊断、靶向治疗和复发。其中,肠细胞的表达、肛周瘘、腹腔镜手术和开腹手术这三个主题引起了持续的高度研究关注:本研究确定了与克罗恩病外科发展相关的关键主题,并为克罗恩病外科领域的未来发展提供了文献计量学见解和展望。
{"title":"Landscape of surgery in Crohn's disease across twenty years: insights from machine learning.","authors":"Zhiyuan Zhou, Chaoran Yu, Bin Liu, Danhua Yao, Yuhua Huang, Pengfei Wang, Yousheng Li","doi":"10.21037/tgh-23-113","DOIUrl":"10.21037/tgh-23-113","url":null,"abstract":"<p><strong>Background: </strong>Crohn's disease continues to be a major component of inflammatory bowel disease with increasing incidence and prevalence. Increasing publications of surgery in Crohn's disease have significantly expanded the research scope. The aim of this study is to characterize main topics and a full landscape of surgery in Crohn's disease.</p><p><strong>Methods: </strong>Studies of surgery in Crohn's disease from 2000 to 2020 were screened and retrieved from the Web of Science Core Collection database. Latent Dirichlet allocation (LDA), one of machine-learning algorithms for natural language processing, was employed for topic modeling. All the studies were processed, analyzed and visualized by R software, CiteSpace and Gephi.</p><p><strong>Results: </strong>A total of 3,697 original publications were identified from the database. USA was the leading country with the most top institutions such as Cleveland Clin Florida and Mayo Clinic and Mayo Foundation. Increasing impact of institutions from Korea and China was also noticed. Bo Shen was the leading author in publication. A machine learning based topic modeling identified major clusters, including disease assessment, surgical treatment and complications, risk factors and epidemiology, disease development and diagnosis, target treatment and recurrence. Three topics attracted continuous high research attention, including expression of intestinal cell, perianal fistula and laparoscopic and open operation.</p><p><strong>Conclusions: </strong>This study identified key topics relating to the development of surgery in Crohn's disease, and provided bibliometric insights and perspectives for future development in the field of surgery in Crohn's disease.</p>","PeriodicalId":94362,"journal":{"name":"Translational gastroenterology and hepatology","volume":"9 ","pages":"64"},"PeriodicalIF":3.8,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11535804/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142585309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Idiopathic acute pancreatitis (IAP)-a review of the literature and algorithm proposed for the diagnostic work-up of IAP. 特发性急性胰腺炎(IAP)--文献综述和 IAP 诊断工作建议算法。
IF 3.8 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-09-13 eCollection Date: 2024-01-01 DOI: 10.21037/tgh-23-125
Anu Aronen, Lucía Guilabert, Amer Hadi, Vytautas Kiudelis, Afrodita Panaitescu, Barbara Wlodarczyk, Johanna Laukkarinen, Sara Regner, Enrique de-Madaria

Background and objective: This narrative review addresses idiopathic acute pancreatitis (IAP) and its epidemiology, diagnosis, clinical course and treatment during the last decade. As there is no previously validated protocol for finding the aetiology of acute pancreatitis (AP), the primary aim of this study is to find, describe and unify evidence about the diagnostic work-up of AP to diagnose the true IAP. By finding the aetiology with the highest possible yield it may be possible to reduce recurrent AP (RAP) episodes and related morbidity and thereby decrease health care costs and possibly improve patients' quality of life.

Methods: This narrative review includes articles retrieved from PubMed search with publications from 2013-2023. Cross references were used when found relevant.

Key content and findings: The rates of aetiologies of AP and the diagnostics performed behind these numbers vary widely between different studies, time periods and different geographical regions, as there is no unified algorithm in diagnostic work-up of IAP. In this study, we describe an up-to-date summary of epidemiology, diagnostic course and treatment of IAP, and propose an algorithm of IAP diagnostics in light of recent scientific studies and their outcomes and address possible treatments of IAP.

Conclusions: Although aetiology is key for AP management, there is still no validated protocol for aetiological diagnosis. IAP is relevant due to its recurrence rate and possible evolution to chronic pancreatitis. We still need more studies addressing this topic and evaluating new diagnostic protocols with advanced tests and treatment strategies in true IAP.

背景和目的:这篇叙述性综述探讨了特发性急性胰腺炎(IAP)及其近十年来的流行病学、诊断、临床过程和治疗。由于以前没有经过验证的急性胰腺炎(AP)病因诊断方案,本研究的主要目的是寻找、描述和统一有关 AP 诊断工作的证据,以诊断真正的 IAP。通过尽可能高的诊断率找到病因,就有可能减少急性胰腺炎(RAP)的反复发作和相关发病率,从而降低医疗成本,并有可能改善患者的生活质量:本叙事性综述包括从 PubMed 检索到的 2013-2023 年间发表的文章。主要内容和研究结果:由于 IAP 的诊断工作没有统一的算法,因此不同研究、不同时期和不同地理区域之间 AP 的病因比率和这些数字背后的诊断方法存在很大差异。在本研究中,我们对 IAP 的流行病学、诊断过程和治疗进行了最新总结,并根据最新的科学研究及其结果提出了 IAP 诊断算法,同时探讨了 IAP 的可能治疗方法:结论:尽管病因学是 AP 治疗的关键,但目前仍没有有效的病因学诊断方案。IAP 的相关性在于其复发率和演变为慢性胰腺炎的可能性。我们仍需要更多的研究来探讨这一主题,并评估针对真正的 IAP 的新诊断方案,包括先进的测试和治疗策略。
{"title":"Idiopathic acute pancreatitis (IAP)-a review of the literature and algorithm proposed for the diagnostic work-up of IAP.","authors":"Anu Aronen, Lucía Guilabert, Amer Hadi, Vytautas Kiudelis, Afrodita Panaitescu, Barbara Wlodarczyk, Johanna Laukkarinen, Sara Regner, Enrique de-Madaria","doi":"10.21037/tgh-23-125","DOIUrl":"10.21037/tgh-23-125","url":null,"abstract":"<p><strong>Background and objective: </strong>This narrative review addresses idiopathic acute pancreatitis (IAP) and its epidemiology, diagnosis, clinical course and treatment during the last decade. As there is no previously validated protocol for finding the aetiology of acute pancreatitis (AP), the primary aim of this study is to find, describe and unify evidence about the diagnostic work-up of AP to diagnose the true IAP. By finding the aetiology with the highest possible yield it may be possible to reduce recurrent AP (RAP) episodes and related morbidity and thereby decrease health care costs and possibly improve patients' quality of life.</p><p><strong>Methods: </strong>This narrative review includes articles retrieved from PubMed search with publications from 2013-2023. Cross references were used when found relevant.</p><p><strong>Key content and findings: </strong>The rates of aetiologies of AP and the diagnostics performed behind these numbers vary widely between different studies, time periods and different geographical regions, as there is no unified algorithm in diagnostic work-up of IAP. In this study, we describe an up-to-date summary of epidemiology, diagnostic course and treatment of IAP, and propose an algorithm of IAP diagnostics in light of recent scientific studies and their outcomes and address possible treatments of IAP.</p><p><strong>Conclusions: </strong>Although aetiology is key for AP management, there is still no validated protocol for aetiological diagnosis. IAP is relevant due to its recurrence rate and possible evolution to chronic pancreatitis. We still need more studies addressing this topic and evaluating new diagnostic protocols with advanced tests and treatment strategies in true IAP.</p>","PeriodicalId":94362,"journal":{"name":"Translational gastroenterology and hepatology","volume":"9 ","pages":"71"},"PeriodicalIF":3.8,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11535791/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142585276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hepatobiliary anastomotic leakage: a narrative review of definitions, grading systems, and consequences of leaks. 肝胆吻合口渗漏:关于渗漏的定义、分级系统和后果的叙述性综述。
IF 3.8 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-09-13 eCollection Date: 2024-01-01 DOI: 10.21037/tgh-24-9
Olivia Rennie, Manaswi Sharma, Nour Helwa

Background and objective: Hepatobiliary diseases are a longstanding and significant medical challenge which, despite advances in surgical techniques, still carry risks for postoperative complications such as anastomotic leaks (ALs), which can include both postoperative pancreatic fistula (POPF) and bile leaks (BL). These complications incur significant human and economic costs on all those involved, including the patient, healthcare providers, and hospital systems. The aim of this study was to construct a narrative review of literature surrounding definitions and grading systems for ALs in the context of hepato-pancreato-biliary (HPB) procedures, and consequences of POPF and BL.

Methods: A literature review was conducted by examining databases including PubMed, Web of Science, OVID Embase, Google Scholar, and Cochrane library databases. Searches were performed with the following search criteria: (((((((anastomosis) OR (anastomotic leak*)) OR (postoperative pancreatic fistula)) OR (bile leak*)) OR (pancreaticoduodenectomy)) OR (whipple)) AND ((hepatobiliary) OR (hepato-pancreato-biliary)) AND ((definition) OR (grading system*) OR (consequences) OR (outcomes) OR (risk factor*) OR (morbidity) OR (mortality))). Publications that were retrieved underwent further assessment to ensure other relevant publications were identified and included.

Key content and findings: A universally accepted definition and grading system for POPF and BL continues to be lacking, leading to variability in reported incidence in the literature. Various groups have worked to publish guidelines for defining and grading POPF and BL, with the International Study Group in Pancreatic Surgery (ISGPS) and International Study Group for Liver Surgery (ISGLS) definitions the current most recommended definitions for POPF and BL, respectively. The burden of AL on patients, healthcare providers, and hospitals is well documented in evidence from leak consequences, such as increased morbidity and mortality, higher reoperation rates, and increased readmission rates, among others.

Conclusions: AL remains a significant challenge in HPB surgery, despite medical advancements. Understanding the progress made in defining and grading leaks, as well as the range of negative outcomes that arise from AL, is crucial in improving patient care, reduce surgical mortality, and drive further advancements in earlier detection and treatment of AL.

背景和目的:肝胆疾病是一项长期存在的重大医学挑战,尽管手术技术不断进步,但术后仍有可能出现吻合口漏(AL)等并发症,其中包括术后胰瘘(POPF)和胆漏(BL)。这些并发症会给患者、医疗服务提供者和医院系统等所有相关人员带来巨大的人力和经济损失。本研究旨在对肝胰胆(HPB)手术中 AL 的定义和分级系统,以及 POPF 和 BL 的后果等相关文献进行叙述性综述:文献综述是通过研究包括 PubMed、Web of Science、OVID Embase、Google Scholar 和 Cochrane 图书馆数据库在内的数据库进行的。检索标准如下:(((((((anastomosis) OR (anastomotic leak*))或(术后胰瘘))或(胆漏*))。或(胰十二指肠切除术))或(Whipple))和((肝胆)或(肝-胰-胆))和((定义)或(分级系统*)或(后果)或(结果)或(风险因素*)或(发病率)或(死亡率)))。对检索到的出版物进行进一步评估,以确保确定并纳入其他相关出版物:目前仍缺乏公认的 POPF 和 BL 的定义和分级系统,导致文献中报告的发病率存在差异。不同团体已致力于发布 POPF 和 BL 的定义和分级指南,其中国际胰腺外科研究组(ISGPS)和国际肝脏外科研究组(ISGLS)的定义分别是目前最推荐的 POPF 和 BL 的定义。AL对患者、医疗服务提供者和医院造成的负担已在泄漏后果的证据中得到充分证明,如发病率和死亡率增加、再次手术率升高、再次入院率升高等:结论:尽管医疗技术在不断进步,但AL仍是HPB手术中的一项重大挑战。了解在漏孔定义和分级方面取得的进展以及 AL 导致的一系列不良后果,对于改善患者护理、降低手术死亡率以及推动早期检测和治疗 AL 的进一步发展至关重要。
{"title":"Hepatobiliary anastomotic leakage: a narrative review of definitions, grading systems, and consequences of leaks.","authors":"Olivia Rennie, Manaswi Sharma, Nour Helwa","doi":"10.21037/tgh-24-9","DOIUrl":"10.21037/tgh-24-9","url":null,"abstract":"<p><strong>Background and objective: </strong>Hepatobiliary diseases are a longstanding and significant medical challenge which, despite advances in surgical techniques, still carry risks for postoperative complications such as anastomotic leaks (ALs), which can include both postoperative pancreatic fistula (POPF) and bile leaks (BL). These complications incur significant human and economic costs on all those involved, including the patient, healthcare providers, and hospital systems. The aim of this study was to construct a narrative review of literature surrounding definitions and grading systems for ALs in the context of hepato-pancreato-biliary (HPB) procedures, and consequences of POPF and BL.</p><p><strong>Methods: </strong>A literature review was conducted by examining databases including PubMed, Web of Science, OVID Embase, Google Scholar, and Cochrane library databases. Searches were performed with the following search criteria: (((((((anastomosis) OR (anastomotic leak*)) OR (postoperative pancreatic fistula)) OR (bile leak*)) OR (pancreaticoduodenectomy)) OR (whipple)) AND ((hepatobiliary) OR (hepato-pancreato-biliary)) AND ((definition) OR (grading system*) OR (consequences) OR (outcomes) OR (risk factor*) OR (morbidity) OR (mortality))). Publications that were retrieved underwent further assessment to ensure other relevant publications were identified and included.</p><p><strong>Key content and findings: </strong>A universally accepted definition and grading system for POPF and BL continues to be lacking, leading to variability in reported incidence in the literature. Various groups have worked to publish guidelines for defining and grading POPF and BL, with the International Study Group in Pancreatic Surgery (ISGPS) and International Study Group for Liver Surgery (ISGLS) definitions the current most recommended definitions for POPF and BL, respectively. The burden of AL on patients, healthcare providers, and hospitals is well documented in evidence from leak consequences, such as increased morbidity and mortality, higher reoperation rates, and increased readmission rates, among others.</p><p><strong>Conclusions: </strong>AL remains a significant challenge in HPB surgery, despite medical advancements. Understanding the progress made in defining and grading leaks, as well as the range of negative outcomes that arise from AL, is crucial in improving patient care, reduce surgical mortality, and drive further advancements in earlier detection and treatment of AL.</p>","PeriodicalId":94362,"journal":{"name":"Translational gastroenterology and hepatology","volume":"9 ","pages":"70"},"PeriodicalIF":3.8,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11535784/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142585199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Precision medicine in metastatic colorectal cancer: targeting KRAS G12C mutation. 转移性结直肠癌的精准医疗:靶向 KRAS G12C 突变。
IF 3.8 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-09-12 eCollection Date: 2024-01-01 DOI: 10.21037/tgh-24-28
Jorge Aparicio
{"title":"Precision medicine in metastatic colorectal cancer: targeting <i>KRAS</i> G12C mutation.","authors":"Jorge Aparicio","doi":"10.21037/tgh-24-28","DOIUrl":"10.21037/tgh-24-28","url":null,"abstract":"","PeriodicalId":94362,"journal":{"name":"Translational gastroenterology and hepatology","volume":"9 ","pages":"53"},"PeriodicalIF":3.8,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11535780/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142585316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An acute progressing hepatic angiosarcoma in a young male diagnosed by contrast-enhanced ultrasound-guided liver needle biopsy: a case report. 造影剂增强超声引导肝穿刺活检确诊的一名年轻男性急性进展期肝血管肉瘤:病例报告。
IF 3.8 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-09-12 eCollection Date: 2024-01-01 DOI: 10.21037/tgh-24-19
Shaojie Chen, Wei Huang, Yuhong Yuan, Xiaofeng Li, Shineng Zhang, Lingyun Wang

Background: Primary hepatic angiosarcoma (PHA) is a rare hepatic malignancy primarily observed in the elderly. It carries a poor prognosis as a result of the characteristics of rapid progression, high aggressiveness, and resistance to traditional chemo- and radiotherapies. Its nonspecific clinical manifestations, along with the lack of laboratory features and various imaging findings, make it hard to recognize in clinic, especially among non-high-risk populations. Hence, pathological diagnosis is essential to establish an accurate diagnosis.

Case description: In the present report, a young male presented with right upper quadrant abdominal pain and hemoperitoneum was eventually diagnosed as hepatic angiosarcoma based on the immunohistochemical staining results of a liver needle biopsy. Contrast-enhanced ultrasound (CEUS) effectively improved the accuracy of the liver needle biopsy in this case. This report describes the epidemiology, presentation, laboratory tests, imaging findings, and pathological features of a rare hepatic angiosarcoma seen in this young male. The patient rapidly developed severe abdominal hemorrhage. Transcatheter hepatic artery embolization, blood transfusions, and symptomatic treatments were administered. The family members abandoned treatment because the patient was in critical condition and could not receive antitumor therapy.

Conclusions: This case emphasizes the significance of pathological findings in the diagnosis of PHA especially in non-high-risk individuals, and the supportive role of CEUS in guiding the liver needle biopsy. Abdominal hemorrhage is one of the serious complications of PHA and transarterial embolization (TAE) should be considered for controlling life-threatening bleeding from ruptured tumor. Further investigation is required to early diagnosis and to improve the prognosis of patients with PHA.

背景:原发性肝血管肉瘤(PHA原发性肝血管肉瘤(PHA)是一种罕见的肝恶性肿瘤,主要见于老年人。它具有进展快、侵袭性强、对传统化疗和放疗耐药等特点,预后较差。由于其临床表现无特异性,加上缺乏实验室特征和各种影像学检查结果,因此在临床上很难识别,尤其是在非高危人群中。因此,病理诊断对于确定准确诊断至关重要:在本报告中,一名年轻男性因右上腹疼痛和腹腔积血而就诊,根据肝穿刺活检的免疫组化染色结果,最终确诊为肝血管肉瘤。对比增强超声(CEUS)有效提高了该病例肝穿刺活检的准确性。本报告描述了一名年轻男性罕见肝血管肉瘤的流行病学、表现、实验室检查、影像学结果和病理学特征。患者迅速出现严重腹腔出血。患者接受了经导管肝动脉栓塞、输血和对症治疗。由于患者病情危重,无法接受抗肿瘤治疗,家属放弃了治疗:本病例强调了病理结果在 PHA 诊断中的重要性,尤其是在非高危人群中,以及 CEUS 在指导肝穿刺活检中的辅助作用。腹腔出血是PHA的严重并发症之一,应考虑经动脉栓塞(TAE)来控制肿瘤破裂引起的危及生命的出血。为了早期诊断和改善 PHA 患者的预后,还需要进一步的研究。
{"title":"An acute progressing hepatic angiosarcoma in a young male diagnosed by contrast-enhanced ultrasound-guided liver needle biopsy: a case report.","authors":"Shaojie Chen, Wei Huang, Yuhong Yuan, Xiaofeng Li, Shineng Zhang, Lingyun Wang","doi":"10.21037/tgh-24-19","DOIUrl":"10.21037/tgh-24-19","url":null,"abstract":"<p><strong>Background: </strong>Primary hepatic angiosarcoma (PHA) is a rare hepatic malignancy primarily observed in the elderly. It carries a poor prognosis as a result of the characteristics of rapid progression, high aggressiveness, and resistance to traditional chemo- and radiotherapies. Its nonspecific clinical manifestations, along with the lack of laboratory features and various imaging findings, make it hard to recognize in clinic, especially among non-high-risk populations. Hence, pathological diagnosis is essential to establish an accurate diagnosis.</p><p><strong>Case description: </strong>In the present report, a young male presented with right upper quadrant abdominal pain and hemoperitoneum was eventually diagnosed as hepatic angiosarcoma based on the immunohistochemical staining results of a liver needle biopsy. Contrast-enhanced ultrasound (CEUS) effectively improved the accuracy of the liver needle biopsy in this case. This report describes the epidemiology, presentation, laboratory tests, imaging findings, and pathological features of a rare hepatic angiosarcoma seen in this young male. The patient rapidly developed severe abdominal hemorrhage. Transcatheter hepatic artery embolization, blood transfusions, and symptomatic treatments were administered. The family members abandoned treatment because the patient was in critical condition and could not receive antitumor therapy.</p><p><strong>Conclusions: </strong>This case emphasizes the significance of pathological findings in the diagnosis of PHA especially in non-high-risk individuals, and the supportive role of CEUS in guiding the liver needle biopsy. Abdominal hemorrhage is one of the serious complications of PHA and transarterial embolization (TAE) should be considered for controlling life-threatening bleeding from ruptured tumor. Further investigation is required to early diagnosis and to improve the prognosis of patients with PHA.</p>","PeriodicalId":94362,"journal":{"name":"Translational gastroenterology and hepatology","volume":"9 ","pages":"76"},"PeriodicalIF":3.8,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11535802/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142585140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Translational gastroenterology and hepatology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1